William A. Hagstrom - May 28, 2025 Form 4 Insider Report for CareDx, Inc. (CDNA)

Role
Director
Signature
/s/ William A. Hagstrom
Stock symbol
CDNA
Transactions as of
May 28, 2025
Transactions value $
-$299,972
Form type
4
Date filed
5/30/2025, 05:57 PM
Previous filing
Jun 18, 2024
Next filing
Jun 13, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HAGSTROM WILLIAM A Director C/O CAREDX, INC., 8000 MARINA BOULEVARD, BRISBANE /s/ William A. Hagstrom 2025-05-30 0001042875

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDNA Common Stock Options Exercise $23.5K +4.75K +8.79% $4.95 58.7K May 28, 2025 Direct
transaction CDNA Common Stock Options Exercise $197K +24.7K +42.14% $7.96 83.5K May 28, 2025 Direct
transaction CDNA Common Stock Options Exercise $2.98K +510 +0.61% $5.85 84K May 28, 2025 Direct
transaction CDNA Common Stock Sale -$523K -30K -35.72% $17.45 54K May 28, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDNA Stock Option (right to buy) Options Exercise $0 -4.75K -100% $0.00 0 May 28, 2025 Common Stock 4.75K $4.95 Direct F2
transaction CDNA Stock Option (right to buy) Options Exercise $0 -24.7K -84.93% $0.00 4.39K May 28, 2025 Common Stock 24.7K $7.96 Direct F3
transaction CDNA Stock Option (right to buy) Options Exercise $0 -510 -100% $0.00 0 May 28, 2025 Common Stock 510 $5.85 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.35 to $17.57, inclusive. The reporting person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
F2 The shares subject to this option vested fully on July 1, 2017.
F3 The shares subject to this option vested fully on June 16, 2024.
F4 The shares subject to this option vested fully on June 17, 2016.